The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Persistent methicillin-resistant Staphylococcus aureus bacteremia: do we need a new therapeutic strategy?

  • Kang, Cheol-In (Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2013.08.22
  • Accepted : 2013.09.10
  • Published : 2013.11.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Tremblay S, Lau TT, Ensom MH. Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence? Ann Pharmacother 2013;47:1045-1054. https://doi.org/10.1345/aph.1R726
  2. Jang HC, Kim SH, Kim KH, et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis 2009;49:395-401. https://doi.org/10.1086/600295
  3. Yoon YK, Kim JY, Park DW, Sohn JW, Kim MJ. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother 2010;65:1015-1018. https://doi.org/10.1093/jac/dkq050
  4. Chong YP, Park SJ, Kim HS, et al. Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Medicine (Baltimore) 2013;92:98-108. https://doi.org/10.1097/MD.0b013e318289ff1e
  5. Park SY, Chong YP, Park HJ, et al. agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci. Infection 2013;41:111-119. https://doi.org/10.1007/s15010-012-0348-0
  6. Uckay I, Bernard L, Buzzi M, et al. High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2012;56:1258-1264. https://doi.org/10.1128/AAC.05808-11
  7. Ok HS, Lee HS, Park MJ, et al. Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study. Korean J Intern Med 2013;28:678-686. https://doi.org/10.3904/kjim.2013.28.6.678
  8. Lai CC, Tan CK, Lin SH, Liao CH, Huang YT, Hsueh PR. Emergence of rifampicin resistance during rifampicin-containing treatment in elderly patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. J Am Geriatr Soc 2010;58:1001-1003. https://doi.org/10.1111/j.1532-5415.2010.02842.x
  9. Liu WL, Hung YL, Lin SH, Lee PI, Hsueh PR. Fatal bacteraemia and infective endocarditis due to meticillinresistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment. Int J Antimicrob Agents 2010;35:615-616. https://doi.org/10.1016/j.ijantimicag.2010.02.009
  10. Park HJ, Kim SH, Kim MJ, et al. Efficacy of linezolidbased salvage therapy compared with glycopeptidebased therapy in patients with persistent methicillinresistant Staphylococcus aureus bacteremia. J Infect 2012;65:505-512. https://doi.org/10.1016/j.jinf.2012.08.007